SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-15-020097
Filing Date
2015-03-31
Accepted
2015-03-31 16:00:24
Documents
10
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K v404831_10k.htm 10-K 927932
2 EXHIBIT 23.1 v404831_ex23-1.htm EX-23.1 2627
3 EXHIBIT 31.1 v404831_ex31-1.htm EX-31.1 9949
4 EXHIBIT 32.1 v404831_ex32-1.htm EX-32.1 4871
  Complete submission text file 0001144204-15-020097.txt   6984462

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rgrx-20141231.xml EX-101.INS 1130336
6 XBRL TAXONOMY EXTENSION SCHEMA rgrx-20141231.xsd EX-101.SCH 51210
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgrx-20141231_cal.xml EX-101.CAL 34879
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgrx-20141231_def.xml EX-101.DEF 254460
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgrx-20141231_lab.xml EX-101.LAB 333059
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgrx-20141231_pre.xml EX-101.PRE 306465
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15070 | Film No.: 15739107
SIC: 2834 Pharmaceutical Preparations